Whilst not definitive, these experiments are consistent with the idea that hESC-EC will retain their TLR4-deficient phenotype in vivo, and supports our hypothesis that, through this property, they would be resistant to atherosclerosis. This evidence concerns the gene TLR4 and atherosclerosis.